Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

New Zealand (NZX) Healthcare Sector Analysis

UpdatedJun 10, 2026
DataAggregated Company Financials
Companies14
  • 7D3.6%
  • 3M-3.2%
  • 1Y-7.3%
  • YTD-7.5%

In the last week, the Healthcare industry is up 3.6%, with Fisher & Paykel Healthcare up 4.1%. However, the industry is down 7.3% over the past year. Looking forward, earnings are forecast to grow by 22% annually.

Sector Valuation and Performance

Has the New Zealand Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 10 Jun 2026NZ$32.6bNZ$20.2bNZ$828.9m16.2x39.4x1.6x
Fri, 08 May 2026NZ$30.9bNZ$20.0bNZ$451.8m18.4x68.3x1.5x
Sun, 05 Apr 2026NZ$31.9bNZ$19.9bNZ$450.7m17.9x70.8x1.6x
Tue, 03 Mar 2026NZ$35.5bNZ$19.6bNZ$445.2m18x79.6x1.8x
Thu, 29 Jan 2026NZ$35.4bNZ$18.3bNZ$535.0m19.9x66.2x1.9x
Sat, 27 Dec 2025NZ$35.4bNZ$18.2bNZ$532.8m20.8x66.4x1.9x
Mon, 24 Nov 2025NZ$35.0bNZ$18.0bNZ$604.7m22.5x57.9x1.9x
Wed, 22 Oct 2025NZ$33.7bNZ$17.7bNZ$573.7m18.8x58.8x1.9x
Fri, 19 Sep 2025NZ$34.1bNZ$17.7bNZ$572.8m17.8x59.6x1.9x
Sun, 17 Aug 2025NZ$36.3bNZ$17.7bNZ$572.6m18.7x63.3x2.1x
Tue, 15 Jul 2025NZ$35.7bNZ$17.7bNZ$572.2m17.9x62.4x2x
Thu, 12 Jun 2025NZ$34.9bNZ$17.4bNZ$567.8m14.4x61.5x2x
Sat, 10 May 2025NZ$35.0bNZ$17.3bNZ$656.0m14.5x53.4x2x
Mon, 07 Apr 2025NZ$34.1bNZ$17.3bNZ$654.3m16.9x52.2x2x
Wed, 05 Mar 2025NZ$33.4bNZ$17.6bNZ$660.8m16.6x50.6x1.9x
Fri, 31 Jan 2025NZ$36.9bNZ$18.2bNZ$733.2m14.5x50.4x2x
Sun, 29 Dec 2024NZ$37.4bNZ$18.2bNZ$727.9m12.4x51.4x2.1x
Tue, 26 Nov 2024NZ$37.6bNZ$18.1bNZ$775.4m25.3x48.4x2.1x
Thu, 24 Oct 2024NZ$37.5bNZ$18.3bNZ$967.8m19.9x38.8x2.1x
Sat, 21 Sep 2024NZ$36.8bNZ$18.1bNZ$964.7m19.5x38.2x2x
Mon, 19 Aug 2024NZ$35.0bNZ$17.6bNZ$975.4m19.8x35.9x2x
Wed, 17 Jul 2024NZ$31.8bNZ$17.8bNZ$977.8m16.8x32.6x1.8x
Fri, 14 Jun 2024NZ$30.5bNZ$17.3bNZ$960.0m17.4x31.8x1.8x
Sun, 12 May 2024NZ$30.2bNZ$17.4bNZ$1.3b23.9x23.4x1.7x
Tue, 09 Apr 2024NZ$29.4bNZ$17.4bNZ$1.3b23.6x22.8x1.7x
Thu, 07 Mar 2024NZ$28.8bNZ$17.0bNZ$1.3b18.6x22.4x1.7x
Sat, 03 Feb 2024NZ$29.7bNZ$16.6bNZ$1.1b20.6x26.2x1.8x
Mon, 01 Jan 2024NZ$29.0bNZ$16.7bNZ$1.1b23.4x25.7x1.7x
Wed, 29 Nov 2023NZ$27.7bNZ$16.6bNZ$1.1b23.8x24.5x1.7x
Fri, 27 Oct 2023NZ$26.8bNZ$16.5bNZ$1.1b31x24.2x1.6x
Sun, 24 Sep 2023NZ$28.3bNZ$16.5bNZ$1.1b28.9x25.6x1.7x
Tue, 22 Aug 2023NZ$28.7bNZ$15.8bNZ$1.1b28.7x26.7x1.8x
Thu, 20 Jul 2023NZ$31.0bNZ$15.8bNZ$1.1b29.6x28.9x2x
Sat, 17 Jun 2023NZ$29.8bNZ$16.0bNZ$1.1b28.8x27.6x1.9x
Price to Earnings Ratio

27.6x


Total Market Cap: NZ$29.8bTotal Earnings: NZ$1.1bTotal Revenue: NZ$16.0bTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Healthcare Sector Price to Earnings3Y Average 44.5x202420252026
Current Industry PE
  • Investors are pessimistic on the New Zealander Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 39.4x which is lower than its 3-year average PE of 44.5x.
  • The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 8.4% per year over the last three years.
  • Meanwhile revenues for these companies have grown 7.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare sector?

NZ Market-0.047%
Healthcare3.63%
Biotech8.93%
Medical Equipment4.08%
Healthcare Services2.59%
Pharma-0.54%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 81.7x.
    • Analysts are expecting annual earnings growth of 13.3%, which is lower than the prior year's growth of 24.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 65% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FPH Fisher & Paykel HealthcareNZ$38.304.1%
+NZ$880.9m		4.2%PE48x
EBO EBOS GroupNZ$20.906.1%
+NZ$248.3m		-43.5%PE15.5x
PEB Pacific EdgeNZ$0.308.9%
+NZ$29.3m		214.4%PS27.5x
SUM Summerset Group HoldingsNZ$8.130.9%
+NZ$17.0m		-27.5%PE7.6x
PHL Promisia HealthcareNZ$0.683.0%
+NZ$1.1m		83.8%PE2.8x

Latest News

RAD
NZ$0.40
Radius Residential Care
7D
-1.3%
1Y
33.9%
EBO
NZ$20.90
EBOS Group
7D
6.1%
1Y
-43.5%
Narrative Update • Jun 07

EBO: Discount Rate Shift Will Support Future Capital Efficiency Reassessment

Analysts have trimmed their NZ$ fair value estimate for EBOS Group from NZ$33.31 to NZ$31.32, citing updated assumptions for discount rates, revenue growth, profit margins and future P/E multiples. What's in the News No recent company specific news, periodical coverage or key development items were provided for EBOS Group, so there are currently no additional news highlights to summarize.
TAH
NZ$4.60
Third Age Health Services
7D
-8.0%
1Y
29.6%
Analysis Article • Jun 05

Third Age Health Services' (NZSE:TAH) Earnings Offer More Than Meets The Eye

Shareholders appeared to be happy with Third Age Health Services Limited's ( NZSE:TAH ) solid earnings report last...
TRU
NZ$0.019
TruScreen Group
7D
5.6%
1Y
-13.6%
PHL
NZ$0.68
Promisia Healthcare
7D
3.0%
1Y
83.8%
Analysis Article • Jun 04

We Think That There Are Issues Underlying Promisia Healthcare's (NZSE:PHL) Earnings

Promisia Healthcare Limited's ( NZSE:PHL ) stock was strong after they recently reported robust earnings. However, we...
OCA
NZ$0.73
Oceania Healthcare
7D
-4.6%
1Y
19.7%
FPH
NZ$38.30
Fisher & Paykel Healthcare
7D
4.1%
1Y
4.2%
Narrative Update • Jun 02

FPH: Strong Earnings And Higher Dividend Will Support Balanced Future Repricing

Analysts have trimmed their price target on Fisher & Paykel Healthcare from NZ$40.59 to NZ$39.63, citing updated assumptions for revenue growth, profit margins, and future P/E multiples. What's in the News Fisher & Paykel Healthcare reported a 14% gain in operating revenue for the 2026 financial year, according to its full year 2026 earnings call highlights.
PEB
NZ$0.30
Pacific Edge
7D
8.9%
1Y
214.4%
AFT
NZ$3.95
AFT Pharmaceuticals
7D
-0.5%
1Y
49.6%
Analysis Article • May 29

AFT Pharmaceuticals' (NZSE:AFT) Profits Appear To Have Quality Issues

Following the solid earnings report from AFT Pharmaceuticals Limited ( NZSE:AFT ), the market responded by bidding up...
SUM
NZ$8.13
Summerset Group Holdings
7D
0.9%
1Y
-27.5%
RUA
NZ$0.029
Rua Bioscience
7D
-3.3%
1Y
7.4%